Cancer Letters
Volume 226, Issue 1 , Pages 27-35 , 8 August 2005

Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo

Received 4 October 2004 ,Revised 25 November 2004 ,Accepted 28 November 2004.

References 

  1. Mattocks AR. Chemistry and Toxicology of Pyrrolizidine Alkaloids. New York: Academic Press; 1986;
  2. Roeder E. Medicinal plants in Europe containing pyrrolizidine alkaloids. Pharmazie. 1995;50:83–98
  3. Roeder E. Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie. 2000;55:711–726
  4. Coulombe RA, Drew GL, Stermitz FR. Pyrrolizidine alkaloids crosslink DNA with actin. Toxicol. Appl. Pharmacol. 1999;154:198–202
  5. Fu PP, Chou MW, Xia Q, Yang Y-C, Yan J, Doerge DR, et al. Genotoxic pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides—mechanisms leading to DNA adduct formation and tumorigenicity. Environ. Carcinogen. Ecotoxicol. Rev. 2001;C19:353–385
  6. Stegelmeier BL, Edgar JA, Steven M, Colegate SM, Gardner DR, Schoch TK, et al. Pyrrolizidine alkaloid plants, metabolism and toxicity. J. Nat. Toxins. 1999;8:5–116
  7. Hincks JR, Kim HY, Segall HJ, Molyneux RJ, Stermitz FR. DNA cross-linking in mammalian cells by pyrrolizidine alkaloids: structure–activity relationships. Toxicol. Appl. Pharmacol. 1991;111:90–98
  8. Kim HY, Stermitz FR, Coulombe RA. Pyrrolizidine alkaloid-induced DNA–protein cross-links. Carcinogenesis. 1995;16:2691–2697
  9. Reed RL, Ahern KG, Pearson GD, Buhler DR. Crosslinking of DNA by dehydroretronecine, a metabolite of pyrrolizidine alkaloids. Carcinogenesis. 1988;9:1355–1356
  10. NTP Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies), Technical Report Series No 508, National Toxicology Program, Research Triangle Park, NC, 2003.
  11. Bruner LH, Carpenter LJ, Hamlow P, Roth RA. Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity. Toxicol. Appl. Pharmacol. 1986;85:416–427
  12. Roth RA, Reindel JF. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite. Adv. Exp. Med. Biol. 1991;283:477–487
  13. Muller L, Kasper P, Kaufmann G. The clastogenic potential in vitro of pyrrolizidine alkaloids employing hepatocyte metabolism. Mutat. Res. 1992;282:169–176
  14. Wilson DW, Segall HJ, Pan LC, Lame MW, Estep JE, Morin D. Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit. Rev. Toxicol. 1992;22:307–325
  15. Kevekordes S, Spielberger J, Burghaus CM, Birkenkamp P, Zietz B, Paufler P, et al Micronucleus formation in human lymphocytes and in the metabolically competent human hepatoma cell line Hep-G2: results with 15 naturally occurring substances. Anticancer Res. 2001;21:461–469
  16. Chan PC, Haseman JK, Prejean JD, Nyska A. Toxicity and carcinogenicity of riddelliine in rats and mice. Toxicol. Lett. 2003;144:295–311
  17. Yang Y-C, Yan J, Doerge DR, Chan P-C, Fu PP, Chou MW. Metabolic activation of the tumorigenic pyrrolizidine alkalois, riddelliine, leading to DNA adduct formation in vivo. Chem. Res. Toxicol. 2001;14:101–109
  18. Chou MW, Yan J, Williams L, Xia Q, Churchwell M, Doerge DR, et al. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid, in vitro and in vivo. Chem. Res. Toxicol. 2003;16:1130–1137
  19. Chou MW, Yan J, Nichols J, Xia Q, Beland FA, Chan PC, et al. Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F1 mice. Cancer Lett. 2003;193:119–125
  20. Mei N, Heflich RH, Chou MW, Chen T. Mutations induced by riddelliine, a carcinogenic pyrrolizidine alkaloid, in the liver cII2 gene of Big Blue transgenic rats. Chem. Res. Toxicol. 2004;17:814–818
  21. Yang Y-C, Yan J, Churchwell M, Beger R, Chan P-C, Doerge DR, et al Development of a 32P-postlabeling/ HPLC method for detection of dehydroretronesine-derived DNA adducts in vitro and in vivo. Chem. Res. Toxicol. 2001;14:91–100
  22. Chou MW, Wang Y-P, Yan J, Yang Y-C, Beger R, Williams LD, et al Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine. Toxicol. Lett. 2003;145:239–247
  23. Mattocks AR, Jukes R. Trapping and measurement of short-lived alkylating agents in a recirculating flow system. Chem. Biol. Interact. 1990;76:19–30
  24. Huxtable RJ, Bowers R, Mattocks AR, Michnicka M. Sulfur conjugates as putative pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline. In:  Witmer CM,  Snyder RR,  Jollow DJ,  Kalf GF,  Kocsis JJ,  Sipes IG editor. Biological Reactive Intermediates:Molecular and Cellular Effects and their Impact on Human Health. vol. 4:New York: Plenum Press; 1991;p. 605–612
  25. Yan CC, Huxtable RJ. Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver. Toxicol. Appl. Pharmacol. 1995;130:132–139
  26. Reid MJ, Lame MW, Morin DD, Wilson W, Segall HJ. Involvement of cytochrome P450 3A in the metabolism and covalent binding of 14C-monocrotaline in rat liver microsomes. J. Biochem. Mol. Toxicol. 1998;12:157–166
  27. Bull LB, Culvenor CC, Dick AJ. The Pyrrolizidine Alkaloids. Their Chemistry, Pathogenicity and other Biological Properties. Amsterdam: North-Holland; 1968;
  28. Cheeke PR. Toxicity and metabolism of pyrrolizidine alkaloids. J. Anim. Sci. 1988;66:2343–2350

PII: S0304-3835(04)00933-4

doi: 10.1016/j.canlet.2004.11.039

Cancer Letters
Volume 226, Issue 1 , Pages 27-35 , 8 August 2005

Article Tools

* Image Usage & Resolution